Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Scenic Biotech logo — Evolution-inspired medicine

Scenic Biotech

Evolution-inspired medicine

Founded 2017 The Netherlands The Netherlands 43 employees Series A Total: $37.60M Biotechnology, Life Sciences

General Information

Company Name Scenic Biotech
Founded Year 2017
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 43
Industries Biotechnology, Life Sciences
Funding Stage Series A
Business Model B2B, Platform, B2B2C
Revenue Model Licensing, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Scenic Biotech. To contact Scenic Biotech, visit scenicbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 17, 2026

Scenic Biotech's CEO, Oscar Izeboud, will be presenting the company's vision at LSX Congress USA on 23 September 2026.

Partnership Talks Sep 17, 2026

Scenic Biotech is seeking to connect with new partners to discuss opportunities in lysosomal biology.

Key Hire Sep 10, 2026

Scenic Biotech welcomes Dr. Judith Walker, MD, as its new Chief Medical Officer, leveraging her 25 years of biopharmaceutical leadership.

Get alerts when Scenic Biotech shows new signals

About Scenic Biotech

Scenic Biotech, founded in 2017 and headquartered in The Netherlands, is focusing on "evolution-inspired medicine" to revolutionize treatments for lysosomal storage disorders and neurodegeneration.

The company is driven by its proprietary Cell-Seq discovery platform, which underpins a robust pipeline targeting neurometabolic diseases. Scenic Biotech's strategy includes leveraging strategic R&D collaborations with industry leaders like Genentech, BMS, Alnylam, and Ono to innovate and expedite the development of novel modifier therapies.

Notably, the company secured a substantial €28.00M Series A investment on 10 March 2022 from prominent investors like BioGeneration Ventures, BioMed Partners, Eir Ventures, Oxford Science Enterprises, Vesalius Biocapital, and Inkef. This funding underscores confidence in Scenic Biotech's potential to unlock new genomic pathways, offering significant promise to investors in the Biotechnology and Life Sciences sectors.

Taxonomy: Evolution-Inspired Medicine, Lysosomal Storage Disorders, Neurodegeneration, Neurometabolic Diseases, Cell-Seq Discovery Platform, Genomics, Immunotherapy Technologies, Genomic Suppressors, Strategic R&D Collaborations, Modifier Therapies, Severe Disease Therapies, Drug Discovery, Drug Development, Pharmaceuticals

Services & Products

Discovery of Modifier Genes
Development of Therapeutics
Collaborations with Pharma Companies
Pipeline Advancement for Neuro and Metabolic Diseases

Target Customers

Pharmaceutical Companies Biotechnology Firms Healthcare Professionals Patients with Genetic Disorders

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €28.00M 6
BioGeneration Ventures BioMed Partners Eir Ventures
BioGeneration Ventures, BioMed Partners +4
10 Mar 2022
Grant €3.10M 1
Netherlands Enterprise Agency
Netherlands Enterprise Agency
23 Jun 2020
Series A €6.50M 3
BioGeneration Ventures Innovations EIS Fund Oxford Science Enterprises
BioGeneration Ventures, Innovations EIS Fund +1
05 Jun 2017

Scenic Biotech Alternatives & Competitors

View All Alternatives
Scenic Biotech vs
Vicinitas Therapeutics
Vicinitas Therapeutics United States

Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for cancer an...

Series A
4 employees
Biotechnology, Health and Wellness
Scenic Biotech vs
Harness Therapeutics
Harness Therapeutics United Kingdom

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases

Venture round
33 employees
Biotechnology, Life Sciences
Scenic Biotech vs
Dynacure
Dynacure France

Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 program with I...

Series C
Biotechnology, Health Care
View all alternatives

FAQ About Scenic Biotech

Evolution-inspired medicine
Scenic Biotech was founded in 2017.
Scenic Biotech is headquartered in The Netherlands.
Scenic Biotech operates in Biotechnology and Life Sciences. Its work centres on Evolution-Inspired Medicine, Lysosomal Storage Disorders, Neurodegeneration and Neurometabolic Diseases. Its customers include Pharmaceutical Companies, Biotechnology Firms and Healthcare Professionals.
Scenic Biotech has a B2B, Platform and B2B2C business model. Its revenue comes from Licensing and Performance Based.
Scenic Biotech has approximately 43 employees.
Scenic Biotech has completed 3 funding rounds, raising a total of $37.60M. The latest funding stage is Series A.
Scenic Biotech offers: Discovery of Modifier Genes, Development of Therapeutics, Collaborations with Pharma Companies, Pipeline Advancement for Neuro and Metabolic Diseases.
Top alternatives and competitors to Scenic Biotech include Vicinitas Therapeutics, Harness Therapeutics, Dynacure, BioAge Labs, Athersys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Scenic Biotech and Vicinitas Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Scenic Biotech, https://bouncewatch.com/company/scenic-biotech, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes